These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34674667)

  • 1. Oral sodium bicarbonate in people on haemodialysis: a randomised controlled trial.
    Kourtellidou SI; Ashby DR; Johansson LR
    BMC Nephrol; 2021 Oct; 22(1):346. PubMed ID: 34674667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: the BiCARB RCT.
    Witham MD; Band M; Chong H; Donnan PT; Hampson G; Hu MK; Littleford R; Lamb E; Kalra PA; Kennedy G; McNamee P; Plews D; Rauchhaus P; Soiza RL; Sumukadas D; Warwick G; Avenell A
    Health Technol Assess; 2020 Jun; 24(27):1-90. PubMed ID: 32568065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial.
    BiCARB study group
    BMC Med; 2020 Apr; 18(1):91. PubMed ID: 32268897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral sodium bicarbonate supplementation on interdialytic weight gain, plasma sodium concentrations and predialysis blood pressure in hemodialysis patients.
    Movilli E; Gaggia P; Camerini C; Brunori G; Vizzardi V; Cancarini G
    Blood Purif; 2005; 23(5):379-83. PubMed ID: 16088106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
    Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study.
    Movilli E; Zani R; Carli O; Sangalli L; Pola A; Camerini C; Cancarini GC; Scolari F; Feller P; Maiorca R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1719-22. PubMed ID: 9681718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.
    Witham MD; Band MM; Littleford RC; Avenell A; Soiza RL; McMurdo ME; Sumukadas D; Ogston SA; Lamb EJ; Hampson G; McNamee P;
    Trials; 2015 Aug; 16():326. PubMed ID: 26231610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial.
    Szeto CC; Wong TY; Chow KM; Leung CB; Li PK
    J Am Soc Nephrol; 2003 Aug; 14(8):2119-26. PubMed ID: 12874466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.
    Melamed ML; Horwitz EJ; Dobre MA; Abramowitz MK; Zhang L; Lo Y; Mitch WE; Hostetter TH
    Am J Kidney Dis; 2020 Feb; 75(2):225-234. PubMed ID: 31699517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of oral sodium bicarbonate supplementation in maintaining acid-base balance and its influence on the cardiovascular system in chronic hemodialysis patients - results of a prospective study.
    Voiculeț C; Zară O; Bogeanu C; Văcăroiu I; Aron G
    J Med Life; 2016; 9(4):449-454. PubMed ID: 27928454
    [No Abstract]   [Full Text] [Related]  

  • 11. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients.
    Movilli E; Viola BF; Camerini C; Mazzola G; Cancarini GC
    J Ren Nutr; 2009 Mar; 19(2):172-7. PubMed ID: 19218045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).
    Gaggl M; Cejka D; Plischke M; Heinze G; Fraunschiel M; Schmidt A; Hörl WH; Sunder-Plassmann G
    Trials; 2013 Jul; 14():196. PubMed ID: 23826760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dialysis sodium gradient on intradialytic hypertension: an observational study.
    Movilli E; Camerini C; Gaggia P; Zubani R; Feller P; Poiatti P; Pola A; Carli O; Valzorio B; Cancarini G
    Am J Nephrol; 2013; 38(5):413-9. PubMed ID: 24216674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients.
    Brady JP; Hasbargen JA
    Am J Kidney Dis; 1998 Jan; 31(1):35-40. PubMed ID: 9428449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term oral sodium bicarbonate supplementation does not improve serum albumin levels in hemodialysis patients.
    Bossola M; Giungi S; Tazza L; Luciani G
    Nephron Clin Pract; 2007; 106(1):c51-6. PubMed ID: 17409769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Sodium Bicarbonate Supplementation Does Not Affect Serum Calcification Propensity in Patients with Chronic Kidney Disease and Chronic Metabolic Acidosis.
    Aigner C; Cejka D; Sliber C; Fraunschiel M; Sunder-Plassmann G; Gaggl M
    Kidney Blood Press Res; 2019; 44(2):188-199. PubMed ID: 31067546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysate bicarbonate variation in maintenance hemodiafiltration patients: Impact on serum bicarbonate, intradialytic hypotension and interdialytic weight gain.
    Viegas M; Cândido C; Felgueiras J; Clemente J; Barros S; Farbota R; Vera F; Matos A; Sousa F
    Hemodial Int; 2017 Jul; 21(3):385-392. PubMed ID: 27761981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients.
    Heguilén RM; Sciurano C; Bellusci AD; Fried P; Mittelman G; Rosa Diez G; Bernasconi AR
    Nephrol Dial Transplant; 2005 Mar; 20(3):591-7. PubMed ID: 15687112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
    Wesson DE; Mathur V; Tangri N; Stasiv Y; Parsell D; Li E; Klaerner G; Bushinsky DA
    Lancet; 2019 Apr; 393(10179):1417-1427. PubMed ID: 30857647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does increasing blood pH stimulate protein synthesis in dialysis patients?
    Ruggieri F; Caso G; Wegmann M; McNurlan MA; Wahl C; Imoberdorf R; Garlick PJ; Ballmer PE
    Nephron Clin Pract; 2009; 112(4):c276-83. PubMed ID: 19546588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.